CoChat

Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook

Open access
Wawrosch, Christoph, Zotchev, Sergey B. · 2021 · Applied Microbiology and Biotechnology
Cited by 246

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Medicinal plants have been used by mankind since ancient times, and many bioactive plant secondary metabolites are applied nowadays both directly as drugs, and as raw materials for semi-synthetic modifications. However, the structural complexity often thwarts cost-efficient chemical synthesis, and the usually low content in the native plant necessitates the processing of large amounts of field-cultivated raw material. The biotechnological manufacturing of such compounds offers a number of advantages like predictable, stable, and year-round sustainable production, scalability, and easier extraction and purification. Plant cell and tissue culture represents one possible alternative to the extraction of phytochemicals from plant material. Although a broad commercialization of such processes has not yet occurred, ongoing research indicates that plant in vitro systems such as cell suspension cultures, organ cultures, and transgenic hairy roots hold a promising potential as sources for bioactive compounds. Progress in the areas of biosynthetic pathway elucidation and genetic manipulation has expanded the possibilities to utilize plant metabolic engineering and heterologous production in microorganisms. This review aims to summarize recent advances in the in vitro production of high-value plant secondary metabolites of medicinal importance. Key points • Bioactive plant secondary metabolites are important for current and future use in medicine • In vitro production is a sustainable alternative to extraction from plants or costly chemical synthesis • Current research addresses plant cell and tissue culture, metabolic engineering, and heterologous production Graphical abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00253-021-11539-w

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 246

Metadata

Authors
Wawrosch, C., & Zotchev, S. B.
Venue
Applied Microbiology and Biotechnology
Published
2021-09
Volume
105
Issue
18
Pages
6649-6668
ISSN
  • 0175-7598 (ISSN-L)
  • 1432-0614
OpenAlex
W3197197775
Cited by
246
References
10
FWCI
9.12
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook. https://app.cochat.ai/papers/10.1007/s00253-021-11539-w
The paper
Wawrosch, C., & Zotchev, S. B. (2021). Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-021-11539-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.